Privacy Policy Terms of Use Disclaimer Sitemap

Orgenesis Inc. Orgenesis Inc.

  • Home
  • About
    • Management Team
    • Overview
    • Board of Directors
    • Advisory Board
  • Markets
    • About Cell Therapy
    • Regnerative Medicine
    • Immuno-Oncology
    • Diabetes
  • Manufacturing Service
    • MaSTherCell
    • Global Facilities/Afilliates
  • Proprietary Therapies
    • Transdifferentiation
    • Indications
    • The Process
    • Publications
    • Patents
  • News & Media
    • Overview
    • Press Releases
    • Events
    • Presentations
    • Video
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap

News & Media

News & Media

News & Media

  • Overview
  • Press Releases
  • Events
  • Presentations
  • Video

Latest NewsFeb 14, 2019

Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018

Recent News

Feb 11, 2019
Orgenesis CEO to Participate in Panel at the 2019 BIO CEO & Investor Conference
Feb 6, 2019
Orgenesis’ CSO Sara Ferber to Present to the International Research Training Group Hosted by Technische Universität Dresden and the King's College London
Feb 5, 2019
Orgenesis Announces the Opening of New Offices and Laboratories at Accessia Pharma in Liège, Belgium to Support its Point of Care Cellular Therapy Platform
Jan 25, 2019
Orgenesis Announces U.S. Expansion of Masthercell Global Subsidiary
View All Press Releases

Latest EventFeb 12, 2019 • 9:00am EST

2019 BIO CEO & Investor Conference
View All Events
© 2019 Orgenesis Inc. All Rights Reserved.